Latest S-1 registration statements

Hashdex Bitcoin ETF files an amendment to its Form S-1 registration statement, outlining its strategy to provide investors with exposure to the bitcoin market through a combination of bitcoin holdings and bitcoin futures contracts.

ArriVent BioPharma is registering an additional 1,597,223 shares of common stock following its initial public offering.

Intuitive Machines registers the issuance and resale of up to 9,411,766 shares of Class A Common Stock related to warrants issued to Armistice Capital Master Fund Ltd.

Trans American Aquaculture, Inc. has filed a pre-effective amendment to its Form S-1 registration statement, covering the offer and resale of up to 533,695,874 shares of common stock by GHS Investments LLC, potentially representing a significant portion of the company's outstanding shares and public float.

Armlogi Holding Corp. files an amendment to its Form S-1 registration statement solely to include an updated consent from ZH CPA, LLC.

YouneeqAI Technical Services is registering 35,814,742 shares of common stock for resale by existing shareholders, with the company not receiving any proceeds.

BrightSpring Health Services files an amended S-1 registration statement, signaling its intent to proceed with an initial public offering and a concurrent offering of tangible equity units.

Panbela Therapeutics is undertaking a best efforts public offering to raise up to $27.8 million for the clinical development of its cancer treatment candidates and for general corporate purposes.

Panbela Therapeutics aims to raise capital through a public offering of common stock and warrants to fund the clinical development of its cancer treatment candidates.

OS Therapies Incorporated files an amendment to its Form S-1 registration statement for a proposed $11.5 million initial public offering and the resale of shares by selling stockholders.

CG Oncology seeks to increase its IPO share offering by 3.45 million shares, including an underwriter option, representing no more than 20% of the initial offering price.

Correlate Energy Corp. has filed an amendment to its registration statement for a proposed public offering of units and pre-funded units, aiming to list its common stock on the NYSE.

Beachbody has filed an S-1 registration statement for the resale of up to 543,590 shares of Class A common stock issuable upon the exercise of outstanding warrants, potentially bringing in $6.1 million if all warrants are exercised for cash.

SINTX Technologies plans to offer units consisting of common stock or pre-funded warrants, along with Class E and Class F warrants, aiming to raise up to $5 million.

1847 Holdings LLC plans to offer up to 2,673,797 common shares and pre-funded warrants to raise capital for debt repayment and general corporate purposes.

FibroBiologics updates its registration statement for a direct listing on the Nasdaq Global Market, anticipating trading to commence around January 31, 2024.

General European Strategic Investments, Inc. files an amendment to its registration statement for a proposed public offering of common stock.

Sagimet Biosciences has filed an amendment to its S-1 registration statement for a proposed offering of 9,000,000 shares of Series A common stock.

AERWINS Technologies launches a public offering of common stock to raise capital and meet Nasdaq listing requirements following a merger and strategic shift towards FAA-compliant MAV development.

Legato Merger Corp. III, a blank check company, aims to raise $175 million through an IPO, targeting businesses in infrastructure, engineering, construction, industrial, and renewables industries for a potential merger.

FibroBiologics updates its registration statement for a direct listing on the Nasdaq Global Market, planning for the resale of up to 4,806,226 shares of common stock by existing stockholders.

General European Strategic Investments, Inc. files an amendment to its registration statement for a proposed public offering of common stock.

Sagimet Biosciences plans to offer 9 million shares of Series A common stock following positive topline results from its FASCINATE-2 Phase 2b clinical trial for NASH treatment.

Expion360 has filed a registration statement for the potential resale of up to 1,781,978 shares of its common stock by Tumim Stone Capital, LLC, under an equity line purchase agreement.

One World Products intends to register for resale up to 21.3 million shares of common stock, including shares issuable to Tysadco Partners, LLC under an equity financing facility.

Digital Locations is shifting its focus to developing technology for high-speed internet delivery from satellites to smartphones and registers 300 million shares for resale by GHS Investments LLC.

ArriVent BioPharma is moving forward with its IPO, offering 8,333,333 shares of common stock with an estimated price range of $17.00 to $19.00 per share.

Pinstripes Holdings has filed a registration statement for the issuance of up to 23,985,000 shares of Class A common stock upon the exercise of outstanding warrants.

Spectral AI, Inc. files an amendment to its S-1 registration statement for the offer and sale of up to 4,050,000 shares of common stock by selling stockholder B. Riley Principal Capital II, potentially raising up to $10 million.

Ozop Energy Solutions is registering up to 1 billion common shares for potential resale by GHS Investments LLC, with the company not receiving proceeds from the resale but from the initial sale to GHS.